PEN is a #3 (Hold) on the Zacks Rank, with a VGM Score of B. Additionally, the company could be a top pick for growth investors. PEN has a Growth Style Score of A, forecasting year-over-year earnings growth of 37.3% for the current fiscal year. Five analysts revised their earnings estimate higher in the last 60 days for fiscal 2024, while the Zacks Consensus Estimate has increased $0.02 to $2.87 per share. PEN also boasts an average earnings surprise of 26%. With a solid Zacks Rank and top-tier Growth and V ...

It has been about a month since the last earnings report for Penumbra (PEN) . Shares have lost about 4.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Penumbra due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts. Penumbra Q1 Earnings Miss, Margins Improve Penumbr ...

ALAMEDA, Calif., June 4, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Truist Securities MedTech Conference on Tuesday, June 18, 2024. Event: Truist Securities MedTech Conference Date: Tuesday, June 18, 2024 Time: 10:05am ET/7:05am PT A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be available on the com ...

ALAMEDA, Calif., May 23, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the William Blair Growth Stock Conference on Thursday, June 6, 2024. Event: William Blair Growth Stock Conference Date: Thursday, June 6, 2024 Time: 12:20pm ET/9:20am PT A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be available on the c ...

Penumbra, Inc. (NYSE:PEN) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Cecilia Furlong - Director of Business Development and Investor Relations Adam Elsesser - President, Chairman and CEO Maggie Yuen - CFO Jason Mills - Executive Vice President of Strategy Conference Call Participants Margaret Kaczor - William Blair Joanne Wuensch - Citi William Plovanic - Canaccord Genuity Fund Robert Marcus - JPMorgan Larry Biegelsen - Wells Fargo Matthew O'Brien - Piper Sandler Michael Sa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from_____ to _____ Commission File Number: 001-37557 Penumbra, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorpor ...

Exhibit 99.1 Penumbra, Inc. Reports First Quarter 2024 Financial Results ALAMEDA, Calif., May 7, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Results Total revenue increased to $278.7 million for the first quarter of 2024 compared to $241.4 million for the first quarter of 2023, an increase of 15.4%, or 15.2% in constant currency . The Uni ...

Penumbra, Inc. (NYSE:PEN) Q4 2023 Earnings Conference Call February 22, 2024 4:30 PM ET Company Participants Jee Hamlyn-Harris – Investor Relations Adam Elsesser – Chairman and Chief Executive Officer Maggie Yuen – Chief Financial Officer Jason Mills – Executive Vice President-Strategy Conference Call Participants Joanne Wuensch – Citi Lei Huang – Wells Fargo Securities, LLC Bill Plovanic – Canaccord Genuity Robbie Marcus – JPMorgan Pito Chickering – Deutsche Bank Michael Sarcone – Jefferies Richard Newitt ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission file number: 001-37557 Penumbra, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of Incorporatio ...

Exhibit 99.1 Penumbra, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results ALAMEDA, Calif., Feb. 22, 2024 /PR Newswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the fourth quarter and full year ended December 31, 2023. Financial Highlights: In the fourth quarter of 2023, the Company made changes to its product revenue categories to provide investors with more meaningful information to understand the performa ...